Raihan Ruksana, Mohamed Rosmawati, Radzi Abu Hassan Muhammad, Md Said Rosaida
Department of Microbiology, Faculty of Medicine, AIMST University, Kedah, Malaysia.
Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Euroasian J Hepatogastroenterol. 2017 Jan-Jun;7(1):65-67. doi: 10.5005/jp-journals-10018-1214. Epub 2017 May 5.
Malaysia is a country where an estimated 1 million people are chronically infected with hepatitis B virus (HBV) and an estimated 2.5% of the adult population are positive for antibody to hepatitis C virus (HCV). Effective nationwide vaccine coverage seems to be a highly effective measure to prevent new HBV infection. Treatment of HCV infection is also a regular practice in Malaysia. These measures highlight the possibility to reach the World Health Organization elimination target by 2030. To achieve this target, the Health Ministry and other nongovernmental organizations, such as My Commitment to Cure (MyC2C) are working together to develop a strategic road map to reach the global elimination target in Malaysia by 2030. Raihan R, Mohamed R, Hasan MRA, Rosaida MS. Chronic Viral Hepatitis in Malaysia: "Where are we now?" Euroasian J Hepato-Gastroenterol 2017;7(1):65-67.
马来西亚是一个估计有100万人长期感染乙肝病毒(HBV)的国家,估计2.5%的成年人口丙肝病毒(HCV)抗体呈阳性。有效的全国疫苗接种覆盖率似乎是预防新的HBV感染的一项高效措施。丙肝病毒感染的治疗在马来西亚也是常规做法。这些措施凸显了到2030年实现世界卫生组织消除目标的可能性。为实现这一目标,卫生部和其他非政府组织,如“我的治愈承诺”(MyC2C),正在共同努力制定一项战略路线图,以在2030年在马来西亚实现全球消除目标。拉伊汉·R、穆罕默德·R、哈桑·MRA、罗赛达·MS。马来西亚的慢性病毒性肝炎:“我们现在处于什么状况?”《欧亚肝脏胃肠病学杂志》2017年;7(1):65 - 67。